Consensus document on COVID-19 vaccination for patients with lymphoedema (Updated 25th May 2021)

Contributors: Professor Peter Mortimer. Professor of Dermatology and Lymphovascular Medicine. Dr Kristiana Gordon. Consultant of Dermatology and Lymphovascular Medicine. Professor Derek Macallan. Professor of Infectious Diseases and Medicine. Professor Sahar Mansour. Professor of Clinical Genetics. Professor Vaughan Keeley. Professor of Palliative Medicine and Lymphoedema. Katie Riches. Lead Research Nurse in Lymphoedema, Breast Cancer and Palliative Medicine. Dr Julian Pearce. Dermatology Registrar and Academic Clinical Fellow.

Comments

This content is published in:

The British Lymphology Society

The British Lymphology Society is a dynamic and innovative body providing a strong professional voice and support for those involved in the care and treatment of people with lymphoedema and related lymphatic disorders, including lipoedema. The Society seeks to achieve high standards of care and equitable access to treatment across the UK and promotes early detection and intervention and, where appropriate, screening and prevention. The Society was established in November of 1985, originally as the British Lymphology Interest Group (BLIG).

Covid-19 wellbeing

This community has been created for health care professionals and patients to share their experiences and knowledge about Covid-19. As Covid-19 is still one of the most prevalent issues globally, it is important to have a space for everybody to feel safe and heard. This community aims to encourage wellbeing and insights into the lives of those working within and those who have been impacted personally by the pandemic.

Lymphoedema

This community is for individuals interested in learning about lymphoedema. Themes include what lymphoedema is, how it can be treated, what type of professionals offer treatment, and how people have lived with it out in the community.

More from this author:

Kate Sinclair

in Lymphoedema

Lymphoedema Acupuncture Activity?

Beverley de Valois PhD LicAc FBAcC MBLS About the Author Beverley de Valois qualified as an acupuncturist in 1999, is a Fellow of the British Acupuncture Council, and was awarded a PhD in 2007. She is a researcher with a special interest in investigating how acupuncture can be used to support cancer survivors, and has conducted many preliminary studies in the Supportive Oncology Research Team (SORT), East and North Hertfordshire NHS Trust at Mount Vernon Cancer Centre. She was Chair of the British Lymphology Society Scientific Committee from 2017-2020.

Kate Sinclair

in Venous Thromboembolism Community

BRITISH LYMPHOLOGY SOCIETY POSITION PAPER FOR THE MANAGEMENT OF PEOPLE WITH LYMPHOEDEMA IN THE PRESENCE OF DEEP VEIN THROMBOSIS (DVT)

The aim of this document is to provide: 1. Practical information for clinical decision-making for health care professionals managing lymphoedema. 2. Key principles for practice. 3. When to safely apply compression in the presence of acute DVT.

Kate Sinclair

in The British Lymphology Society

MEET YOUR SECRET WEAPONS FOR A HEALTHY LYMPHATIC SYSTEM

Why movement is your best defence against lymphoedema. You’ll find lots of tips for how to get started with lymphoedema-safe movement on thebls.com.

Kate Sinclair

in The British Lymphology Society

MANAGING LYMPHOEDEMA AFTER TREATMENT FOR HEAD AND NECK CANCER

This is the second Lymph Fact Sheet addressing lymphoedema following treatment for head and neck cancer. Life-long risk reducing activities for patients at risk of lymphoedema in the head and neck have already been described and this fact sheet focuses on the identification, impact and different management strategies used for lymphoedema in the head and neck region. It’s intended to support lymphoedema practitioners who may be referred this group of patients for management of their swelling.

Kate Sinclair

in Covid-19 wellbeing